BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

AgaMatrix, Inc. Elects Jeffrey B. Kindler to its Board of Directors


8/22/2012 10:01:11 AM

SALEM, N.H., Aug. 22, 2012 /PRNewswire/ -- AgaMatrix, Inc. today announced the election of Jeffrey B. Kindler to the company's Board of Directors.

Mr. Kindler, 56, was previously Chairman and CEO of Pfizer Inc. He joined Pfizer in January 2002 as Executive Vice-President and General Counsel. Before joining Pfizer, Mr. Kindler was an executive at McDonald's Corporation, where he served as President of Partner Brands and as Executive Vice President and General Counsel. Prior to that, he was Vice President, Litigation and Legal Policy, at the General Electric Company and, before that, a partner at the Washington D.C. law firm of Williams & Connolly.

"Jeff brings extensive public company leadership and experience to the AgaMatrix Board," said John Alberico, CEO and President. "Our company is at a stage where Jeff's guidance will be essential, as we prepare for the next logical steps in the organization's development."

Mr. Kindler is a trustee of Tufts University and a member of the board of the National Center on Addiction and Substance Abuse at Columbia University. He serves on the board of a number of privately held health care companies and is a director of Starboard Capital Partners, a Connecticut-based private equity firm. He earned his J.D. from Harvard University, magna cum laude, and his B.A. from Tufts University, summa cum laude.

About AgaMatrix
AgaMatrix is a private company based in Salem, New Hampshire, that invents, develops, manufactures and markets a line of blood glucose meters, biosensors (test strips) and diabetes management software for home, clinic and mobile applications. AgaMatrix's products are designed to improve the quality of diabetes care by using the company's proprietary WaveSense technology to personalize each test to provide world class accuracy. The technology employs a new detection method called Dynamic Electrochemistry® to detect and correct for many errors caused by differences in blood samples and environmental conditions. Current AgaMatrix products include the KeyNote®, Presto® and WaveSense Jazz® blood glucose meters, and the WaveSense Diabetes Manager iPhone® App. AgaMatrix's line of blood glucose meters and test strips are covered by insurance and are available by mail order and at popular retail outlets. For more product information, go to: http://www.agamatrix.com.

© 2002-2012 AgaMatrix, Inc., AgaMatrix, WaveSense, Dynamic Electrochemistry, KeyNote, Presto, WaveSense Jazz and WaveSense Diabetes Manager are trademarks of AgaMatrix, Inc. iPhone is a registered trademark of Apple Inc.

SOURCE AgaMatrix, Inc.



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES